Andreas Rump

Andreas Rump

Auto-generated profile, based on publicly available information

Andreas Rump

Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2001 in Nature
Verified
Journal Article
Open access
PDF file
ELEric S. Lander
Eric S. Lander
LLLauren M. Linton
Lauren M. Linton
BBBruce Birren
Bruce Birren
CNChad Nusbaum
Chad Nusbaum
MZMichael C. Zody
Michael C. Zody
MMMichael J. Morgan
Michael J. Morgan
The human genome holds an extraordinary trove of information about human development, physiology, medicine and evolution. Here we report the results of an international collaboration to produce and make freely available a draft sequence of the human genome. We also present an initial analysis of the data, describing some of the insights that can be gleaned from the sequence.

1 November 2012 in The Lancet
Verified
Journal Article
Closed access
ARAnita Rauch
Anita Rauch
DWDagmar Wieczorek
Dagmar Wieczorek
EGElisabeth Graf
Elisabeth Graf
TWThomas Wieland
Thomas Wieland
SESabine Endele
Sabine Endele
TSTim M Strom
Tim M Strom

18 May 2000 in Nature
Verified
Journal Article
Closed access
PDF file
MHM. Hattori
M. Hattori
AFA. Fujiyama
A. Fujiyama
TTT. D. Taylor
T. D. Taylor
HWH. Watanabe
H. Watanabe
TYT. Yada
T. Yada
MYM.-L. Yaspo
M.-L. Yaspo

1 May 1997 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
ERErcole Rao
Ercole Rao
BWBirgit Weiss
Birgit Weiss
MFMaki Fukami
Maki Fukami
ARAndreas Rump
Andreas Rump
BNBeate Niesler
Beate Niesler
GRGudrun A. Rappold
Gudrun A. Rappold

29 June 2003 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
PMPhilomena Mburu
Philomena Mburu
MMMirna Mustapha
Mirna Mustapha
AVAnabel Varela
Anabel Varela
DWDominique Weil
Dominique Weil
Aziz El-AmraouiAziz El-Amraoui
Aziz El-Amraoui
SBSteve D M Brown
Steve D M Brown

25 January 2022 in Journal of Clinical Oncology
Verified
Journal Article
Open access
SLShuai Li
Shuai Li
VSValentina Silvestri
Valentina Silvestri
GLGoska Leslie
Goska Leslie
TRTimothy R. Rebbeck
Timothy R. Rebbeck
SNSusan L. Neuhausen
Susan L. Neuhausen
AAAntonis C. Antoniou
Antonis C. Antoniou
PURPOSE: To provide precise age-specific risk estimates of cancers other than female breast and ovarian cancers associated with pathogenic variants (PVs) in BRCA1 and BRCA2 for effective cancer risk management. METHODS: We used data from 3,184 BRCA1 and 2,157 BRCA2 families in the Consortium of Investigators of Modifiers of BRCA1/2 to estimate age-specific relative (RR) and absolute risks for 22 first primary cancer types adjusting for family ascertainment. RESULTS: BRCA1 PVs were associated with risks of male breast (RR = 4.30; 95% CI, 1.09 to 16.96), pancreatic (RR = 2.36; 95% CI, 1.51 to 3.68), and stomach (RR = 2.17; 95% CI, 1.25 to 3.77) cancers. Associations with colorectal and gallbladder cancers were also suggested. BRCA2 PVs were associated with risks of male breast (RR = 44.0; 95% CI, 21.3 to 90.9), stomach (RR = 3.69; 95% CI, 2.40 to 5.67), pancreatic (RR = 3.34; 95% CI, 2.21 to 5.06), and prostate (RR = 2.22; 95% CI, 1.63 to 3.03) cancers. The stomach cancer RR was higher for females than males (6.89 v 2.76; P = .04). The absolute risks to age 80 years ranged from 0.4% for male breast cancer to approximately 2.5% for pancreatic cancer for BRCA1 carriers and from approximately 2.5% for pancreatic cancer to 27% for prostate cancer for BRCA2 carriers. CONCLUSION: In addition to female breast and ovarian cancers, BRCA1 and BRCA2 PVs are associated with increased risks of male breast, pancreatic, stomach, and prostate (only BRCA2 PVs) cancers, but not with the risks of other previously suggested cancers. The estimated age-specific risks will refine cancer risk management in men and women with BRCA1/2 PVs.